300705.SZ
Hunan Jiudian Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 10.92
−5.62%Year over year
Reported trailing growth
- Revenue
- -0.8%
- EBITDA
- —
- EBIT
- -20.8%
- EPS
- -22.6%
- Free cash flow
- —
- Operating cash flow
- -11.9%
Forward estimates
Based on analyst estimates
- Revenue
- -77.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +10.2%
- EBITDA
- +23.5%
- EBIT
- +22.7%
- Net income
- +20.6%
- EPS
- +5.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026